S. Tansey

730 total citations
17 papers, 548 citations indexed

About

S. Tansey is a scholar working on Epidemiology, Microbiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, S. Tansey has authored 17 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Microbiology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in S. Tansey's work include Pneumonia and Respiratory Infections (10 papers), Bacterial Infections and Vaccines (8 papers) and Respiratory viral infections research (7 papers). S. Tansey is often cited by papers focused on Pneumonia and Respiratory Infections (10 papers), Bacterial Infections and Vaccines (8 papers) and Respiratory viral infections research (7 papers). S. Tansey collaborates with scholars based in United States, United Kingdom and Netherlands. S. Tansey's co-authors include William C. Gruber, Daniel A. Scott, Emilio A. Emini, Thomas R. Jones, Eelko Hak, Theo Verheij, Diederick E. Grobbee, E. A. M. Sanders, Brent Thoma and Marc J. M. Bonten and has published in prestigious journals such as The Journal of Pediatrics, Journal of Antimicrobial Chemotherapy and Vaccine.

In The Last Decade

S. Tansey

17 papers receiving 526 citations

Peers

S. Tansey
N. Faelli Italy
Claire Phillips United Kingdom
Kathleen A. Woodin United States
A. Madhi South Africa
Romina Libster Argentina
Uzochukwu Egere United Kingdom
M. Farley United States
S. Tansey
Citations per year, relative to S. Tansey S. Tansey (= 1×) peers Roberta Cavagna

Countries citing papers authored by S. Tansey

Since Specialization
Citations

This map shows the geographic impact of S. Tansey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Tansey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Tansey more than expected).

Fields of papers citing papers by S. Tansey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Tansey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Tansey. The network helps show where S. Tansey may publish in the future.

Co-authorship network of co-authors of S. Tansey

This figure shows the co-authorship network connecting the top 25 collaborators of S. Tansey. A scholar is included among the top collaborators of S. Tansey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Tansey. S. Tansey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tansey, S., et al.. (2025). A blueprint for TFF format selection: Hollow fibers and flat sheets for ultrafiltration of AAV. Separation and Purification Technology. 370. 133064–133064. 2 indexed citations
2.
Davis, Jonathan M., Gerri Baer, Susan McCune, et al.. (2019). Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials. The Journal of Pediatrics. 219. 243–249.e1. 14 indexed citations
3.
Gadzinowski, Janusz, S. Tansey, Jacek Wysocki, et al.. (2014). Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine Manufactured With and Without Polysorbate 80 Given to Healthy Infants at 2, 3, 4 and 12 Months of Age. The Pediatric Infectious Disease Journal. 34(2). 180–185. 6 indexed citations
4.
Hoff, William van’t, et al.. (2013). NIHR Medicines for Children Research Network: improving children’s health through clinical research. Expert Review of Clinical Pharmacology. 6(5). 581–587. 18 indexed citations
5.
Silfverdal, Sven‐Arne, Carl‐Erik Flodmark, Lars Rombo, et al.. (2013). 13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): A phase 3, open-label trial. Vaccine. 31(9). 1284–1292. 6 indexed citations
6.
Lalwani, Sanjay, Ashish Bavdekar, Sundaram Balasubramanian, et al.. (2012). Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Vaccines in India. The Pediatric Infectious Disease Journal. 32(5). 509–516. 16 indexed citations
7.
Vellinga, Akke, et al.. (2012). Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model. Journal of Antimicrobial Chemotherapy. 67(10). 2523–2530. 38 indexed citations
8.
Gadzinowski, Janusz, Piotr Albrecht, Ryszard Konior, et al.. (2011). Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine. Vaccine. 29(16). 2947–2955. 17 indexed citations
9.
Daniëls, Tessa M. John, Eva Galiza, et al.. (2010). Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age. The Pediatric Infectious Disease Journal. 29. 4 indexed citations
10.
Snape, Matthew D., Tessa M. John, Eva Galiza, et al.. (2010). Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age. The Pediatric Infectious Disease Journal. 29(12). e80–e90. 102 indexed citations
11.
Wysocki, Jacek, et al.. (2010). Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines. Vaccine. 28(49). 7779–7786. 7 indexed citations
12.
13.
Snape, Matthew D., Andrew J. Pollard, S. Baker, et al.. (2008). Immunogenicity of DTaP-IPV-Hib and MenC vaccines in the UK when administered with a 13-valent pneumococcal conjugate vaccine. ePrints Soton (University of Southampton). 5 indexed citations
14.
Hak, Eelko, Diederick E. Grobbee, E. A. M. Sanders, et al.. (2008). Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.. PubMed. 66(9). 378–83. 132 indexed citations
15.
Alfirevic, Z., Kees Boer, Paul Brocklehurst, et al.. (1999). Two trials of antenatal thyrotrophin‐releasing hormone for fetal maturation: stopping before the due date. BJOG An International Journal of Obstetrics & Gynaecology. 106(9). 898–906. 8 indexed citations
16.
Ryan, William J., et al.. (1998). Tracheoesophageal speech: Predictors of success and social validity ratings. American Journal of Otolaryngology. 19(1). 12–17. 24 indexed citations
17.
Tulloh, Robert, S. Tansey, Karan Parashar, et al.. (1994). Echocardiographic screening in neonates undergoing surgery for selected gastrointestinal malformations.. Archives of Disease in Childhood Fetal & Neonatal. 70(3). F206–F208. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026